Post Profile






House panel: Mylan CEO minimized EpiPen profits in testimony

Leaders of the House Oversight Committee want EpiPen maker Mylan to explain why the company's CEO apparently misled Congress about profits the company claimed for the life-saving EpiPen injection device. … Click to Continue »
read more

share

Related Posts


The maker of EpiPen just made a big change to the story it told Congress last week (MYL)

Business & Finance : Business Insider: Money Game

This is quite the oversight. The maker of EpiPen, pharmaceutical company Mylan, is now saying that it understated the profits it derives from the life-saving drug by 60% in a Congressional hearing last week, according to Dow Jones. ...

Mylan CEO defends EpiPen prices

Business & Finance : USAToday: Money

The CEO of Mylan defended the price of the company's Epipen product during a House Oversight and Government Reform Committee hearing Wednesday. (Sept. 21)        

Here's what to expect when the CEO of EpiPen-maker Mylan testifies before Congress (MYL)

Business & Finance : Business Insider: Money Game

Heather Bresch, the CEO of Mylan — which makes the EpiPen — will be testifying in front of  the House Oversight and Government Reform Committee Wednesday afternoon about the drug's price. The price device, used in emergencies to tre...

Mylan CEO Explains To Congress Why EpiPen Prices Rose 550% in 9 Years - Live Feed

Business & Finance : Zero Hedge

Mylan chief executive Heather Bresch, the daughter of Sen. Joe Manchin (D-W.Va.), has been called by The House Oversight Committee to explain why she has significantly increased the price of the EpiPen, an auto-injector used to trea...

LIVE: 'A simple and corrupt business model' — Congress rails on the maker of EpiPen (MYL)

Politics : Business Insider: Politix

Heather Bresch, the CEO of Mylan — which makes the EpiPen — is testifying in front of  the House Oversight and Government Reform Committee about the drug's price after an hour-long delay. The price device, used in emergencies to tre...

Comments


Copyright © 2016 Regator, LLC